U.S. President Donald Trump announced Friday that nine pharmaceutical companies, including Merck, Bristol Myers Squibb and Amgen, agreed to reduce certain U.S. drug prices to levels comparable with prices in other wealthy countries.
Pharma Companies Agree to Cut U.S. Drug Prices in Trump Deal